| 产品详情 |
| Edit |   |
|---|
| Product Name | Natalizumab (Tysabri®) BioAssay™ ELISA Kit |
|---|
| Description | Natalizumab (Tysabri®) is a humanized monoclonal antibody against the cell adhesion molecule alpha4-integrin used in the treatment of multiple sclerosis and Crohn's disease. Tysabri® and was previously named Antegren®. Natalizumab is administered by intravenous infusion every 28 days and reduces the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood-brain barrier Sample Type: Serum and plasma Intended Use: The Natalizumab BioAssay™ ELISA kit is designed to measure free Natalizumab with high specificity and sensitivity in biological matrices. Sensitivity: 1.5ng/ml Recovery: 250ng/mL of Natalizumab was spiked in 10 lots of human serum. Recovery ranges are from 90-108% with an average recovery of 96%. Precision: Intra-assay CV: <10% Inter-assay CV: <10%. Specificity: Human IgG1 and rituximab prepared at 250ng/mL were assayed and exhibited no crossreactivity or interference. Test Principle: This assay employs the sandwich enzy |
|---|
| Size | 96 tests |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 384863 |
|---|
| Price | |
|---|
| Order / More Info | Natalizumab (Tysabri®) BioAssay™ ELISA Kit from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|